Abstract
Photodynamic therapy (PDT) with aminolevulinic acid (ALA) or methyl aminolevulinate (MAL) is an approved modality for the non-invasive treatment of actinic keratoses (AK) and basal cell carcinoma (BCC) offering excellent cosmetic outcome. However, pain during and after illumination is the most frequent and limiting side effect. The aim of this study was to precisely assess how reported pain during PDT is influenced by sex, age, treatment site, disease (AK/BCC) as well as the photosensitizer used. 467 lesions consisting of AK (primary treatments: n = 158; follow-up: n = 47) or BCC (primary treatments: n = 138; follow-up: 124) were treated by ALA- or MAL-PDT using metal halide lamps (580–750 nm). Pain was assessed during illumination using a continuous visual analogue scale (VAS). Factors predictive for higher pain levels during PDT are treatment of the head, treating AK and using ALA. The observed results may improve patient management and predict which level of pain to expect, and what kind of pain relief to prepare.
Similar content being viewed by others
References
P. Babilas, M. Landthaler, R. M. Szeimies, Photodynamic therapy in dermatology, Eur. J. Dermatol., 2006, 16, 340–348.
P. Babilas, S. Karrer, A. Sidoroff, M. Landthaler, R. M. Szeimies, Photodynamic therapy in dermatology—an update, Photodermatol. Photoimmunol. Photomed., 2005, 21, 142–149.
C. Abels, C. Fritsch, K. Bolsen, R. M. Szeimies, T. Ruzicka, G. Goerz, A. E. Goerz, Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo, J. Photochem. Photobiol., B, 1997, 40, 76–83.
E. H. Tschen, D. S. Wong, D. M. Pariser, F. E. Dunlap, A. Houlihan, M. B. Ferdon, Phase IV ALA-PDT Actinic Keratosis Study Group, Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up, Br. J. Dermatol., 2006, 155, 1262–1269.
P. Foley, Clinical efficiacy of methyl aminolevulinate (Metvix) photodynamic therapy, J. Dermatol. Treat., 2003, 14, 15–22.
C. A. Morton, Methyl aminolevulinate actinic keratoses and Bowen’s disease, Dermatol. Clin., 2007, 25, 81–87.
C. Morton, S. Campbell, G. Gupta, S. Keohane, J. Lear, I. Zaki, S. Walton, N. Kerrouche, G. Thomas, P. Soto, Aktion Investigators, Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study, Br. J. Dermatol., 2006, 155, 1029–1036.
M. Berker, B. Hughes, Using a tool for pain assessment, Nurs. Times, 1990, 86, 50–52.
C. A. Morton, Realizing the cosmetic potential of topical photodynamic therapy, J. Cosmet. Dermatol., 2002, 1, 66–71.
G. Dragieva, J. Hafner, R. Dummer, P. Schmid-Grendelmeier, M. Roos, B. M. Prinz, G. Burg, U. Binswanger, W. Kempf, Topical photodynamic therapy in the treatment of actinic keratoses and Bowen’s disease in transplant recipients, Transplantation, 2004, 77, 115–121.
S. Fijan, H. Hönigsmann, B. Ortel, Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine, Br. J. Dermatol., 1995, 133, 282–288.
S. R. Wiegell, I. M. Stender, R. Na, H. C. Wulf, Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin, Arch. Dermatol., 2003, 139, 1173–1177.
A. Kasche, S. Luderschmidt, J. Ring, R. Hein, Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid, J. Drugs Dermatol., 2006, 5, 353–356.
S. M. Langan, P. Collins, Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses, Br. J. Dermatol., 2006, 154, 146–149.
C. Sandberg, B. Stenquist, I. Rosdahl, A. M. Ros, I. Synnerstad, M. Karlsson, F. Gudmundson, M. B. Ericson, O. Larkö, A. M. Wennberg, Important factors for pain during photodynamic therapy for actinic keratosis, Acta Derm. Venereol., 2006, 86, 404–408.
J. Skiveren, M. Haedersdal, P. A. Philipsen, S. R. Wiegell, H. C. Wulf, Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study, Acta Derm. Venereol., 2006, 86, 409–411.
P. Babilas, M. Landthaler, R. M. Szeimies, Actinic keratoses, Hautarzt, 2003, 54, 551–560.
A. M. Wennberg, O. Larko, P. Lennroth, G. Larson, A. L. Krogstad, Delta-aminolevulinic acid in superficial basal cell carcinomas and normal skin–a microdialysis and perfusion study, Clin. Exp. Dermatol., 2000, 25, 317–22.
S. Grapengiesser, M. Ericson, F. Gudmundsson, O. Larkö, A. Rosén, A. M. Wennberg, Pain caused by photodynamic therapy of skin cancer, Clin. Exp. Dermatol., 2002, 27, 493–497.
I. Wang, Photodynamic Therapy and Laser-Based Diagnostic Studies of Malignant Tumours, Dissertation, Lund University, Lund, Sweden, 1999.
R. Agostino, G. Cruccu, G. Iannetti, A. Romaniello, A. Truini, M. Manfredi, Topographical distribution of pinprick and warmth thresholds to CO2 laser stimulation on the human skin, Neurosci. Lett., 2000, 285, 115–118.
E. Rud, O. Gederaas, A. Høgset, K. Berg, 5-aminolevulinic acid, but not 5-aminolevulinic acid esters, is transported into adenocarcinoma cells by system BETA transporters, Photochem. Photobiol., 2000, 71, 640–647.
R. R. Edwards, N. B. Fillingim, T. J. Ness, Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults, Pain, 2003, 101, 155–165.
M. W. Heft, B. Y. Cooper, K. K. O’Brien, E. Hemp, R. O’Brien, Aging effects on the perception of noxious and non-noxious thermal stimuli applied to the face, Aging (Milano), 1996, 8, 35–41.
R. R. Edwards, R. B. Fillingim, Age-associated differences in responses to noxious stimuli, J. Gerontol. A: Biol. Sci. Med. Sci., 2001, 56, M180–M185.
R. R. Edwards, R. B. Fillingim, T. J. Ness, Age-related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults, Pain, 2003, 101, 155–165.
R. R. Edwards, D. M. Doleys, D. Lowery, R. B. Filligim, Pain tolerance as a predictor of outcome following multidisciplinary treatment for chronic pain: differential effects as a function of sex, Pain, 2003, 106, 419–426.
D. Lowery, R. B. Fillingim, R. A. Wright, Sex differences and incentive effects on perceptual and cardiovascular responses to cold pressor pain, Psychosom. Med., 2003, 65, 284–291.
D. L. Mahony, W. J. Burroughs, A. C. Hieatt, The effects of laughter on discomfort thresholds: does expectation become reality?, J. Gen. Psychol., 2001, 128, 217–226.
Y. Sharav, M. Tal, Focussed analgesia and generalized relaxation produce differential hypnotic analgesia in response to ascending stimulus intensity, Int. J. Psychophysiol., 2004, 52, 187–196.
M. P. Goldman, C. Merial-Kieny, T. Nocera, S. Mery, Comparative benefit of two thermal spring waters after photodynamic therapy procedure, J. Cosmet. Dermatol., 2007, 6, 31–35.
H. J. McQuay, M. Tramèr, B. A. Nye, D. Carroll, P. J. Wiffen, R. A. Moore, A systematic review of antidepressants in neuropathic pain, Pain, 1996, 68, 217–227.
K. H. Todd, K. G. Funk, J. P. Funk, R. Bonacci, Clinical significance of reported changes in pain severity, Ann. Emerg. Med., 1996, 27, 485–489.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steinbauer, J.M., Schreml, S., Babilas, P. et al. Topical photodynamic therapy with porphyrin precursors—assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 8, 1111–1116 (2009). https://doi.org/10.1039/b823378k
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b823378k